Clarus Therapeutics (BLUW) Return on Equity (ROE) (2025 - 2026)

Clarus Therapeutics (BLUW) Return on Equity (ROE) from Sep 30, 2025 to Mar 31, 2026. The TTM Clarus Therapeutics (BLUW) Return on Equity (ROE) is 0.76%. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.